ArticleScience advances2026
Rapid and robust diagnosis of bloodstream infections by single-cell analysis.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sepsis, a common consequence of bloodstream infection (BSI), is a leading cause of global mortality and morbidity. Diagnosis is challenging and slow due to extremely low pathogen loads and reliance on time-consuming blood culture, necessitating empiric therapy that worsens outcomes and antimicrobial resistance. Here, we introduce sedimentation-assisted tandem rocking and enrichment for analysis and monitoring (STREAM), a platform that efficiently isolates and enriches pathogens near their natural doubling times directly from whole blood. By integrating STREAM with single-cell analysis, we achieved rapid and robust diagnosis of BSI from whole-blood samples. Using molecularly barcoded sequential fluorescence in situ hybridization, pathogen identification in 104 positive blood culture samples showed 96.15% concordance with clinical laboratory results. Gel-based single-cell antimicrobial susceptibility testing yields 97.96% essential agreement and 93.9% categorical agreement across 219 drug-dose combinations. The platform enabled comprehensive BSI diagnosis directly from whole blood, achieving a detection limit as low as 0.1 to 1 CFU/ml and delivering full diagnostic results within 6.75 to 17 hours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.